Blog

Science

Predicting the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL) – The Princess Máxima Center for Pediatric Oncology

The Princess Máxima Center for Pediatric Oncology/LinkedIn

Dec 16, 2024, 13:20

Predicting the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL) – The Princess Máxima Center for Pediatric Oncology

The Princess Máxima Center for Pediatric Oncology posted on LinkedIn:

“Two new studies start thanks to funding from KWF Kankerbestrijding (Dutch Cancer Society) – Alpe d’HuZes. Ruben van Boxtel, Maarten Geurts and Friso Calkoen want to be able to predict the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL). And Jorik van Rijn aims to find leads for the development of CAR T cell therapy for children with T-lymphoblastic leukemia or lymphoma (T-LBLL).”

Predicting the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL) - The Princess Máxima Center for Pediatric Oncology

Alpe d'HuZes. Ruben van Boxtel cancer CAR T-cell therapy Dutch Cancer Society Friso Calkoen Jorik van Rijn KWF Dutch Cancer Society Maarten Geurts OncoDaily Oncology T-lymphoblastic leukemia The Princess Máxima Center Pediatric Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage